ACB $1.430 (1.42%)
ACNNF $0.030 (0%)
AERO $3.210 (0%)
ALEAF $0.050 (-14.97%)
AMMJ $0.048 (12.81%)
APHA $15.380 (0%)
ARNA $99.990 (0%)
ATT:CNX $0.080 (0%)
AUSA:CNX $0.065 (0%)
AUSAF $0.050 (0%)
AVXL $11.060 (-0.98%)
BAMM:CNX $0.130 (0%)
BBM:CNX $0.030 (-14.29%)
BBRRF $0.027 (-3.27%)
BE:CNX $0.005 (0%)
BIO:CNX $0.013 (0%)
BLIS:CNX $0.315 (0%)
BLO:CNX $0.395 (2.6%)
BLOZF $0.308 (2.5%)
BUDZ $0.100 (-9.09%)
CADMF $0.052 (0%)
CALI:CNX $0.085 (13.33%)
CANN $0.230 (-2.13%)
CARA $9.060 (-6.69%)
CBWTF $0.062 (0.16%)
CGC $2.540 (-0.97%)
CGRW $0.016 (-22%)
CHOO:CNX $0.005 (0%)
CHOOF $0.003 (-16%)
CNBX $3.990 (0%)
CNGGF $0.203 (0%)
CODI $22.680 (0.22%)
CPMD $0.020 (-4.81%)
CRBP $0.281 (0.07%)
CRON $3.050 (0.33%)
CROP:CNX $0.015 (0%)
CSI:CNX $0.070 (-12.5%)
CURR $0.349 (2.65%)
CVSI $0.033 (7.49%)
DIGP $0.014 (0%)
EEVVF $0.078 (0%)
EMHTF $0.039 (10.17%)
EPWCF $0.059 (0%)
FFT:CNX $0.040 (0%)
FNNZF $0.075 (13.64%)
GNBT $0.001 (0%)
GRIN:CNX $0.075 (-16.67%)
GRWG $4.840 (-1.83%)
GTBIF $10.150 (-1.46%)
GTII:CNX $13.090 (-1.65%)
GWPH $218.960 (0%)
HEXO $0.196 (-0.56%)
HHPHF $0.079 (0%)
HLSPY $0.363 (0%)
HMLSF $2.800 (0%)
HMPPF $0.498 (0%)
HRVOF $0.023 (-11.07%)
HSTRF $0.135 (0%)
HUGE:CNX $1.180 (-1.67%)
IAN:CNX $0.075 (0%)
IGC $0.520 (-3.02%)
IGXT $0.219 (13.76%)
IIPR $92.910 (-2.5%)
INQD $0.009 (-3.23%)
IONC:CNX $0.005 (0%)
IONKF $0.005 (-2.04%)
ISOL:CNX $0.035 (0%)
ITHUF $0.062 (5.65%)
KBEV:CNX $0.045 (0%)
KHRNF $0.091 (-2.15%)
KSHB $0.695 (0%)
LHS:CNX $1.470 (0%)
LHSIF $1.145 (0%)
LXX:CNX $8.400 (0%)
MCIG $0.028 (0%)
MEDIF $0.057 (1.15%)
MGWFF $0.060 (9.57%)
MJ:CNX $0.050 (0%)
MJNA $0.015 (1.4%)
MNTR $0.040 (0%)
MYM:CNX $0.140 (0%)
MYMMF $0.106 (0%)
NCNNF $0.058 (0%)
NDVAF $0.111 (-6.17%)
NGW:CNX $0.410 (0%)
NRXCF $0.035 (0%)
NSPDF $0.010 (-23.53%)
NVTQF $0.596 (0%)
NWKRF $0.424 (0%)
NXGWF $0.316 (0%)
NXTTF $0.033 (6.61%)
OH:CNX $5.330 (0%)
ORHOF $4.050 (0%)
PHCG $0.001 (0%)
PHVAF $0.038 (0%)
PILL:CNX $0.230 (-17.86%)
PKG:CNX $0.020 (-20%)
PLPRF $0.357 (0%)
PLUS:CNX $0.440 (0%)
PMCB $2.420 (0%)
PNPL $0.012 (0%)
PTNYF $0.018 (3.24%)
QCA:CNX $0.095 (-5%)
RDDTF $0.020 (1.53%)
RLLVF $0.001 (0%)
RMHB $0.028 (2.8%)
RQB:CNX $0.005 (0%)
RQHTF $0.448 (2.99%)
SLNG:CNX $0.095 (-9.52%)
SMG $83.180 (-1.21%)
SNN:CNX $0.155 (0%)
SOL:CNX $0.320 (0%)
SOLCF $0.250 (0%)
SPLIF $0.016 (-15.79%)
SPRWF $0.268 (0%)
STEM:CNX $0.035 (0%)
STMH $0.028 (1.45%)
SUN:CNX $0.150 (0%)
TBPMF $0.052 (3.82%)
TCAN:CNX $0.135 (0%)
TCNAF $0.080 (0%)
TER:CNX $3.480 (-0.57%)
TGEN $1.200 (0%)
TGIF:CNX $0.025 (-16.67%)
TGIFF $0.020 (-12.28%)
THC:CNX $0.048 (0%)
THCBF $0.044 (12.85%)
TLRY $3.540 (1.14%)
TRLFF $0.035 (0%)
TRSSF $2.710 (0.37%)
TURV $0.001 (0%)
VIDA:CNX $0.055 (0%)
VIN:CNX $0.015 (0%)
VPRB $0.047 (-6%)
VRTHF $0.026 (0%)
VVCIF $0.035 (-8.14%)
WAYL:CNX $0.740 (0%)
XXII $1.740 (-12.12%)
ZDPY $0.740 (-2.63%)
ZYNE $1.190 (-0.83%)
GW Pharmaceuticals plc (GWPH) has once again changed the landscape of the cannabis industry as the company reported its second positive Stage 3 Clinical trial for its Epidiolex product.The results for this trial were for the treatment of Lennox-Gastaut syndrome (LGS) and Epidiolex was able to significantly reduce the number…
Yesterday, Chuck Rosenberg, who is the new head of the Drug Enforcement Agency (DEA), made the following statement at the agency’s headquarters. “Heroin is clearly more dangerous than marijuana.”Last week, Rosenberg said marijuana is probably not as dangerous as heroin and the press had a field day over his statement.…
Painkillers have become a serious issue in the United States. During the past 15 years, America has seen a tremendous growth in both the sales of prescription opiates and the number of people who die each year from abusing them. According to the Center for Disease Control (CDC), painkillers accounted…
During the first five months of 2015, the number of people who have died from synthetic marijuana has tripled when compared to the same period last year. On Thursday, the Centers for Disease Control and Prevention (CDC) issued a report that said 15 people have died this year from synthetic…
Nemus Bioscience Inc. (NMUS) is a biopharmaceutical company focused on developing cannabis-based therapeutics for the treatment of a variety of diseases. Although Technical420 currently has a Hold rating on shares of NMUS, we see long term potential for the following reasons: 1) Their partnership with the University of Mississippi (UM) offers the…
The biotech sector has been and will continue to be one greatest beneficiaries of the growth in the cannabis industry. The sector is comprised of the most credible cannabis companies; some of which trade on the NASDAQ. There are also a number of biotech companies trading on the over-the-counter (OTC)…
Today, Smart Approaches to Marijuana will present a plan to officials in Washington that aims to ease restrictions on scientific research into marijuana. The group was co-founded by former United States Congressman Patrick Kennedy and opposes the legalization of marijuana.Kevin Sabet, the president of Smart Approaches to Marijuana said, "Let's put research…
On Monday, Pennsylvania Governor Tom Wolf hosted marijuana supporters at his residence for what he described as a chance to get the facts out. This comes after State Representative Matt Baker stated that he will not advance Senate Bill 3 because cannabis is not approved by the FDA.Senate Bill 3…
Pennsylvania State Republican Representative Matt Baker is a perfect example of what is wrong with politicians. Although the Pennsylvania Senate decisively passed Senate Bill 3 which would legalize medical marijuana and 88% of Pennsylvania voters support legalizing medical marijuana, the bill could be stalled indefinitely if Representative Baker has his…
Two weeks ago, the Iowa Senate passed Senate File 484 which expands upon the number of conditions that qualifies patients for medical marijuana. The bill would allow up to four growers regulated by the state to sell marijuana through independent dispensaries.Iowa law allows patients who suffer from epilepsy access to…